DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Aurora inhibitor
Aurora inhibitor
Aurora Kinase a in Gastrointestinal Cancers: Time to Target Ahmed Katsha1, Abbes Belkhiri1, Laura Goff3 and Wael El-Rifai1,2,4*
Structure-Based Discovery and Bioactivity Evaluation of Novel
Spatiotemporal Dynamics of Aurora B-PLK1-MCAK Signaling Axis
The Aurora B Kinase Activity Is Required for the Maintenance of the Differentiated State of Murine Myoblasts
Quantitative Conformational Profiling of Kinase Inhibitors Reveals Origins of Selectivity for Aurora Kinase Activation States
Functional Interplay Between NF-Κb-Inducing Kinase and C-Abl
BRAF Testing in Advanced Colorectal Cancer: Is It Ready for Prime Time?
Inhibition of Aurora a and Aurora B Is Required for the Sensitivity of HPV
Dual PDK1/Aurora Kinase a Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation
Inhibition of Aurora B Kinase Sensitizes a Subset of Human Glioma Cells to TRAIL Concomitant with Induction of TRAIL-R2
A Framework for Identification of Actionable Cancer Genome
(12) United States Patent (10) Patent No.: US 8,633,210 B2 Us M
Aurora Kinase
In-Silico Investigation of Coenzyme a Selectivity for Aurora a Kinase and Development of an Aurora a Kinase- Selective Inhibitor As a Potential Anticancer Agent
Inhibition of Mtor Pathway Sensitizes Acute Myeloid Leukemia Cells to Aurora Inhibitors by Suppression of Glycolytic Metabolism
China Japan United States Europe
Combined Cisplatin and Aurora Inhibitor Treatment Increase
A Systems Chemical Biology Approach for Dissecting Differential
Top View
Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma
Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma
Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer Via Suppression of Aurora Kinase A/B Expression
Selective Targeting of CTNBB1-, KRAS- Or MYC-Driven Cell Growth by Combinations of Existing Drugs
A Novel Target of the Aurora Kinase Inhibitor Tozasertib (VX-680)
Effects of the Aurora Kinase Inhibitor VX-680 on Anaplastic Thyroid Cancer-Derived Cell Lines
Aurora Kinase Inhibition Induces PUMA Via NF-Kb to Kill Colon Cancer Cells
Aurora-A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene
Chromosomal)Instability)In)Glioma)Stem)Cell) Lines)From)Glioblastoma)Multiforme:)) Implications)For)New)Therapeutic)Strategies) ' ' ' ' ' '
Daurinol Enhances the Efficacy of Radiation Therapy in Lung Cancer Via Suppression of Aurora Kinase A/B Expression
Selective Inhibition of Aurora Kinase a by AK-01/LY3295668 Attenuates MCC Tumor Growth by Inducing MCC Cell Cycle Arrest and Apoptosis
Targeting AURKA in Cancer: Molecular Mechanisms And
Sirna Screening of the Kinome Identified Aurora a Kinase As a Therapeutic Target Gene in Cervical Cancer Fawzi Faisal A
The Aurora Kinase Inhibitor SNS-314 Shows Broad Therapeutic Potential with Chemotherapeutics and Synergy with Microtubule-Targeted Agents in a Colon Carcinoma Model
Aurora a Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene
Crystal Structure and Inhibitor Identifications Reveal Targeting
A Framework for Identification of Actionable Cancer Genome
The Azaindole Framework in the Design of Kinase Inhibitors